• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于双变量混合模型的两种物种数据对弥漫性大 B 细胞淋巴瘤进行基因选择和癌症类型分类。

Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.

机构信息

Dr. Su's Statistics, Department of Human Nutrition, Food, and Animal Sciences, University of Hawaii at Manoa, Honolulu, HI 96822, USA.

出版信息

Hum Genomics. 2013 Jan 5;7(1):2. doi: 10.1186/1479-7364-7-2.

DOI:10.1186/1479-7364-7-2
PMID:23289441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3618031/
Abstract

: A bivariate mixture model utilizing information across two species was proposed to solve the fundamental problem of identifying differentially expressed genes in microarray experiments. The model utility was illustrated using a dog and human lymphoma data set prepared by a group of scientists in the College of Veterinary Medicine at North Carolina State University. A small number of genes were identified as being differentially expressed in both species and the human genes in this cluster serve as a good predictor for classifying diffuse large-B-cell lymphoma (DLBCL) patients into two subgroups, the germinal center B-cell-like diffuse large B-cell lymphoma and the activated B-cell-like diffuse large B-cell lymphoma. The number of human genes that were observed to be significantly differentially expressed (21) from the two-species analysis was very small compared to the number of human genes (190) identified with only one-species analysis (human data). The genes may be clinically relevant/important, as this small set achieved low misclassification rates of DLBCL subtypes. Additionally, the two subgroups defined by this cluster of human genes had significantly different survival functions, indicating that the stratification based on gene-expression profiling using the proposed mixture model provided improved insight into the clinical differences between the two cancer subtypes.

摘要

提出了一种利用两种物种信息的双变量混合模型,以解决微阵列实验中鉴定差异表达基因的基本问题。该模型的实用性通过北卡罗来纳州立大学兽医学院的一组科学家准备的狗和人类淋巴瘤数据集进行了说明。确定了一小部分在两个物种中均差异表达的基因,并且该聚类中的人类基因可作为将弥漫性大 B 细胞淋巴瘤 (DLBCL) 患者分为两个亚组的良好预测因子,即生发中心 B 细胞样弥漫性大 B 细胞淋巴瘤和激活 B 细胞样弥漫性大 B 细胞淋巴瘤。与仅进行单物种分析(人类数据)所鉴定的人类基因数量(190)相比,从双物种分析中观察到的人类基因中显著差异表达的数量(21)非常少。这些基因可能具有临床相关性/重要性,因为这个小基因集实现了低的 DLBCL 亚型误分类率。此外,由该簇人类基因定义的两个亚组具有显著不同的生存功能,表明使用提出的混合模型基于基因表达谱进行分层提供了对两种癌症亚型之间临床差异的深入了解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b8/3618031/cda6699ce02f/1479-7364-7-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b8/3618031/2cc0f1c158f0/1479-7364-7-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b8/3618031/cda6699ce02f/1479-7364-7-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b8/3618031/2cc0f1c158f0/1479-7364-7-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73b8/3618031/cda6699ce02f/1479-7364-7-2-2.jpg

相似文献

1
Gene selection and cancer type classification of diffuse large-B-cell lymphoma using a bivariate mixture model for two-species data.基于双变量混合模型的两种物种数据对弥漫性大 B 细胞淋巴瘤进行基因选择和癌症类型分类。
Hum Genomics. 2013 Jan 5;7(1):2. doi: 10.1186/1479-7364-7-2.
2
Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.弥漫性大B细胞淋巴瘤中与临床分子亚型及预后相关的免疫相关长链非编码RNA生物标志物的发现与验证
Mol Cancer. 2017 Jan 19;16(1):16. doi: 10.1186/s12943-017-0580-4.
3
A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy.一种新的免疫染色算法可将弥漫性大B细胞淋巴瘤高精度地分类为分子亚型。
Clin Cancer Res. 2009 Sep 1;15(17):5494-502. doi: 10.1158/1078-0432.CCR-09-0113. Epub 2009 Aug 25.
4
Clinicopathological characteristics and genomic profile of primary sinonasal tract diffuse large B cell lymphoma (DLBCL) reveals gain at 1q31 and RGS1 encoding protein; high RGS1 immunohistochemical expression associates with poor overall survival in DLBCL not otherwise specified (NOS).原发性鼻窦弥漫性大B细胞淋巴瘤(DLBCL)的临床病理特征和基因组图谱显示1q31区域获得以及编码RGS1蛋白;RGS1免疫组化高表达与未另行指定(NOS)的DLBCL患者总生存期较差相关。
Histopathology. 2017 Mar;70(4):595-621. doi: 10.1111/his.13106. Epub 2017 Jan 9.
5
Immunohistochemical classification of de novo, transformed, and relapsed diffuse large B-cell lymphoma into germinal center B-cell and nongerminal center B-cell subtypes correlates with gene expression profile and patient survival.初发、转化和复发的弥漫性大B细胞淋巴瘤免疫组化分类为生发中心B细胞和非生发中心B细胞亚型,与基因表达谱及患者生存率相关。
Arch Pathol Lab Med. 2006 Dec;130(12):1819-24. doi: 10.5858/2006-130-1819-ICODNT.
6
Downregulation of USP18 reduces tumor-infiltrating activated dendritic cells in extranodal diffuse large B cell lymphoma patients.USP18 的下调减少了结外弥漫性大 B 细胞淋巴瘤患者肿瘤浸润的活化树突状细胞。
Aging (Albany NY). 2021 May 17;13(10):14131-14158. doi: 10.18632/aging.203030.
7
Diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤。
Pathology. 2018 Jan;50(1):74-87. doi: 10.1016/j.pathol.2017.09.006. Epub 2017 Nov 20.
8
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.弥漫性大B细胞淋巴瘤的分子亚型通过不同的遗传途径产生。
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13520-5. doi: 10.1073/pnas.0804295105. Epub 2008 Sep 2.
9
A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.一种基于基因表达的方法来诊断弥漫性大B细胞淋巴瘤的临床不同亚组。
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9991-6. doi: 10.1073/pnas.1732008100. Epub 2003 Aug 4.
10
Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment.基于反映肿瘤和微环境的 2 个基因表达的弥漫性大 B 细胞淋巴瘤的生存预测。
Blood. 2011 Aug 4;118(5):1350-8. doi: 10.1182/blood-2011-03-345272. Epub 2011 Jun 13.

引用本文的文献

1
Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel.通过人类热点基因panel对犬T细胞淋巴瘤进行比较肿瘤学DNA测序。
Oncotarget. 2018 Apr 27;9(32):22693-22702. doi: 10.18632/oncotarget.25209.
2
Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation.淋巴瘤细胞系和原发性淋巴瘤的比较高分辨率转录组测序揭示了细胞系特异性的通路失调。
Sci Rep. 2018 Apr 19;8(1):6279. doi: 10.1038/s41598-018-23207-7.
3
Comparative oncology: what dogs and other species can teach us about humans with cancer.

本文引用的文献

1
Expression of LMO2 is associated with t(14;18)/IGH-BCL2 fusion but not BCL6 translocations in diffuse large B-cell lymphoma.LMO2 的表达与弥漫性大 B 细胞淋巴瘤中的 t(14;18)/IGH-BCL2 融合有关,但与 BCL6 易位无关。
Am J Clin Pathol. 2010 Aug;134(2):278-81. doi: 10.1309/AJCPATUP1D0HGCUG.
2
Aggressive lymphomas.侵袭性淋巴瘤。
N Engl J Med. 2010 Apr 15;362(15):1417-29. doi: 10.1056/NEJMra0807082.
3
Prognostic immunophenotypic biomarker studies in diffuse large B cell lymphoma with special emphasis on rational determination of cut-off scores.
比较肿瘤学:狗和其他物种能让我们了解患癌人类的哪些方面。
Philos Trans R Soc Lond B Biol Sci. 2015 Jul 19;370(1673). doi: 10.1098/rstb.2014.0231.
4
Man's best friend: what can pet dogs teach us about non-Hodgkin's lymphoma?人类最好的朋友:宠物狗能让我们对非霍奇金淋巴瘤有哪些了解?
Immunol Rev. 2015 Jan;263(1):173-91. doi: 10.1111/imr.12238.
5
Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.剖析非霍奇金淋巴瘤大型动物模型的调控微环境:FOXP3+ T细胞对犬B细胞淋巴瘤预后产生负面影响的证据。
PLoS One. 2014 Aug 13;9(8):e105027. doi: 10.1371/journal.pone.0105027. eCollection 2014.
6
Global gene expression analysis of canine cutaneous mast cell tumor: could molecular profiling be useful for subtype classification and prognostication?犬皮肤肥大细胞瘤的全基因表达分析:分子谱分析对亚型分类和预后评估是否有用?
PLoS One. 2014 Apr 18;9(4):e95481. doi: 10.1371/journal.pone.0095481. eCollection 2014.
弥漫性大 B 细胞淋巴瘤预后免疫表型标志物研究,特别强调截取值的合理确定。
Leuk Lymphoma. 2010 Feb;51(2):199-212. doi: 10.3109/10428190903370338.
4
The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients.NTPDase 的活性和表达在多发性硬化症患者的淋巴细胞中发生改变。
Clin Chim Acta. 2010 Feb;411(3-4):210-4. doi: 10.1016/j.cca.2009.11.005. Epub 2009 Nov 13.
5
Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival.生发中心B细胞样(GCB)和活化B细胞样(ABC)型弥漫性大B细胞淋巴瘤(DLBCL):分子预测指标、特征、细胞周期状态及患者生存分析
Cancer Inform. 2007 Dec 12;3:399-420.
6
Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP.活化B细胞聚焦分类对接受R-CHOP治疗的弥漫性大B细胞淋巴瘤患者的预后影响
Mod Pathol. 2009 Aug;22(8):1094-101. doi: 10.1038/modpathol.2009.73. Epub 2009 May 15.
7
Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development.与调节细胞周期、细胞凋亡和淋巴细胞发育的基因种系变异相关的非霍奇金淋巴瘤风险。
Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1259-70. doi: 10.1158/1055-9965.EPI-08-1037. Epub 2009 Mar 31.
8
Stromal gene signatures in large-B-cell lymphomas.大B细胞淋巴瘤中的基质基因特征
N Engl J Med. 2008 Nov 27;359(22):2313-23. doi: 10.1056/NEJMoa0802885.
9
NCBI GEO: archive for high-throughput functional genomic data.NCBI基因表达综合数据库:高通量功能基因组数据存档库。
Nucleic Acids Res. 2009 Jan;37(Database issue):D885-90. doi: 10.1093/nar/gkn764. Epub 2008 Oct 21.
10
Prognostic markers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience.弥漫性大B细胞淋巴瘤亚组中的预后标志物与基因异常:单中心经验
Croat Med J. 2008 Oct;49(5):618-24. doi: 10.3325/cmj.2008.5.618.